Fact CheckerSign in

NCT05274971Completed

Diet and Exercise on Ambulatory Blood Pressure

Dietary Management and Aerobic Exercise on 24-hour Ambulatory Blood Pressure in Subjects with Prehypertension and Drug-naïve Stage 1 Hypertension: Randomized, Single-blinded Clinical Trial

Source: ClinicalTrials.gov · Last updated 26 Oct 2024

Brief summary (registry, in English)

This is a multicenter, randomized, single-blinded clinical trial investigating the effect of dietary management and active aerobic exercise training on reduction of 24-hour ambulatory blood pressure in subjects with prehypertension and drug-naïve stage 1 hypertension.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
5 Feb 2022
Start date
15 May 2022
Primary completion date
1 Nov 2023
Lead sponsor
Korea University Anam Hospital
NCT number
NCT05274971

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 15 May 2022 to the primary completion date, 1 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients under anti-hypertensive medications
  • Patients under hormone replacement therapy or other steroids

Other illness

  • Patients with suspected or confirmed secondary hypertension
  • Patients with medical conditions that potentially affect blood pressure, including neurological disorders, gastrointestinal diseases, or malignancy.

Lab values

  • Patients with abnormal liver function tests (transaminases more than three times the upper limit of normal)
  • Patients with peripheral edemas and/or baseline serum creatinine level above 2.0 mg/dL

Other

  • Patients without aerobic exercise tolerance

Who the study is looking for

  • Age 18-80 years
  • Prehypertension or grade 1 hypertension, defined as a systolic blood pressure of 130 to 159 mm Hg and/or a diastolic blood pressure of 85 to 99 mm Hg
  • Patients without previous use of anti-hypertensive medication

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Korea University Anam Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.